OLEMA PHARMACEUTICALS INC (OLMA): Hedge Fund Ownership & Smart Money Signals (Q4 2025)

OLEMA PHARMACEUTICALS INC (OLMA)

208 + Investors. Track Smart Money conviction in OLMA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — OLMA

Based on 198 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds added OLMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

198 hedge funds hold OLMA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +32% more funds vs a year ago

fund count last 6Q

+48 new funds entered over the past year (+32% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 74% buying

145 buying52 selling

Last quarter: 145 funds were net buyers (86 opened a brand new position + 59 added to an existing one). Only 52 were sellers (40 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+65 vs last Q)

new funds entering per quarter

Funds opening a new OLMA position: 26 → 17 → 21 → 86. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

📌

Mixed — 37% long-term, 34% new

■ 37% conviction (2yr+) ■ 28% medium ■ 34% new

Of the 198 current holders: 74 (37%) held >2 years, 56 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💰

Value +239% but shares only +35% — price-driven

Value

+239%

+34%

Last quarter: the total dollar value of institutional holdings rose +239%, but actual share count only changed +35%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

34 → 26 → 17 → 21 → 86 new funds/Q

New funds entering each quarter: 26 → 17 → 21 → 86. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Deep conviction — 49% of holders stayed 2+ years

■ 49% veterans ■ 15% 1-2yr ■ 37% new

Of 208 current holders: 101 (49%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

✅

Strong quality — 30% AUM from major funds

30% from top-100 AUM funds

32 of 198 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.3

out of 10

Moderate Exit Risk

Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2025 Q4)	Prior (2025 Q3)	Change
Funds Holding	208	127	63.78%
13F Shares	92M	69M	34.5%
Total Value	$2.28B	$671M	239.49%
New Positions	90	22	+68
Increased Positions	64	40	+24
Closed Positions	13	16	-3
Reduced Positions	42	39	+3
Total Calls	8	4	100.0%
Total Puts	5	1	400.0%
PUT/CALL Ratio	0.62	0.25	Bullish

Metric

All 13F Filers (2025 Q4)

Prior (2025 Q3)

Change

Funds Holding

208

127

63.78%

13F Shares

92M

69M

34.5%

Total Value

$2.28B

$671M

239.49%

New Positions

+68

Increased Positions

+24

Closed Positions

-3

Reduced Positions

Total Calls

100.0%

Total Puts

400.0%

PUT/CALL Ratio

0.62

0.25

Bullish

Institutional Holders (2026 Q1)

208 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in OLMA. Verified SEC 13F-HR filings.

FILTER:All New Added To Reduced No Change | Overweight >5% | SHOW: Active managers + show index funds

Top 25 institutional holders of OLMA — 2025 Q4 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	PSP Research LLC	0.11%	10,000	$149K
2	TEMA ETFS LLC	0.08%	79,243	$1.2M
3	FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.	0.06%	116,812	$1.7M
4	Candriam S.C.A.	0.06%	759,513	$11.3M
5	PROFUND ADVISORS LLC	0.03%	58,577	$873K
6	Y-Intercept (Hong Kong) Ltd	0.03%	90,375	$1.3M
7	Inscription Capital, LLC	0.02%	15,273	$228K
8	China Universal Asset Management Co., Ltd.	0.02%	14,225	$212K
9	E Fund Management Co., Ltd.	0.01%	16,533	$247K
10	WOLFF WIESE MAGANA LLC	0.00%	600	$9K
11	Pictet Asset Management Holding SA	0.00%	217,023	$3.2M
12	Police & Firemen's Retirement System of New Jersey	0.00%	19,191	$286K
13	AlphaQuest LLC	0.00%	1,690	$42K
14	Versant Capital Management, Inc	0.00%	1,379	$21K
15	Wealthspire Advisors, LLC	0.00%	10,172	$152K
16	Arizona State Retirement System	0.00%	10,368	$155K
17	Swedbank AB	0.00%	55,100	$822K
18	Physician Wealth Advisors, Inc.	0.00%	391	$6K
19	Sterling Capital Management LLC	0.00%	2,314	$35K
20	STRS OHIO	0.00%	10,500	$157K
21	KLP KAPITALFORVALTNING AS	0.00%	8,300	$124K
22	GF FUND MANAGEMENT CO. LTD.	0.00%	1,767	$26K
23	GAMMA Investing LLC	0.00%	588	$9K
24	NISA INVESTMENT ADVISORS, LLC	0.00%	5,864	$87K
25	ProShare Advisors LLC	0.00%	13,710	$204K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — OLEMA PHARMACEUTICALS INC (OLMA)

What does the Smart Money Trend signal show for OLMA?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added OLMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for OLMA?

More buyers than sellers — 74% buying: Last quarter: 145 funds were net buyers (86 opened a brand new position + 59 added to an existing one). Only 52 were sellers (40 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for OLMA holders?

Strong quality — 30% AUM from major funds: 32 of 198 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held OLMA?

Mixed — 37% long-term, 34% new: Of the 198 current holders: 74 (37%) held >2 years, 56 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

OLEMA PHARMACEUTICALS INC (OLMA)

Smart Money Signals — OLMA

Buying streak — 2 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +32% more funds vs a year ago

More buyers than sellers — 74% buying

More new buyers each quarter (+65 vs last Q)

Mixed — 37% long-term, 34% new

Value +239% but shares only +35% — price-driven

Acceleration phase — new buyers rushing in

Deep conviction — 49% of holders stayed 2+ years

Strong quality — 30% AUM from major funds

Hedge Fund Ownership: OLMA

Market Analysis: OLMA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: OLMA

Hedge Fund Positioning: OLMA

Statistics: OLMA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — OLEMA PHARMACEUTICALS INC (OLMA)

Welcome to 13Foresight!